The syndrome of inappropriate antidiuretic hormone secretion is characterized by excessive water uptake and hyponatremia. The extent of hyponatremia, however, is less than anticipated, which is ascribed to a defense mechanism, the vasopressin-escape, and is suggested to involve a tonicity-determined down-regulation of the water channel aquaporin-2 (AQP2). The underlying mechanism, however, is poorly understood. To study this, we used the mouse cortical collecting duct (mpkCCD) cell line. MpkCCD cells, transfected with an AQP2-promoter luciferase construct showed a reduced and increased AQP2 abundance and transcription following culture in hypotonic and hypertonic medium, respectively. This depended on tonicity rather than osmolality and occurred independently of the vasopressin analog dDAVP, cAMP levels, or protein kinase A activity. Although prostaglandins and nitric oxide reduced AQP2 abundance, inhibition of their synthesis did not influence tonicity-induced AQP2 transcription. Also, cells in which the cAMP or tonicity-responsive element (CRE/TonE) in the AQP2-promoter were mutated showed a similar response to hypotonicity. Instead, the tonicity-responsive elements were pin-pointed to nucleotides ؊283 to ؊252 and ؊157 to ؊126 bp. In conclusion, our data indicate that hypotonicity reduces AQP2 abundance and transcription, which occurs independently of vasopressin, cAMP, and the known TonE and CRE in the AQP2-promoter. Increased prostaglandin and nitric oxide, as found in vivo, may contribute to reduced AQP2 in vasopressin-escape, but do not mediate the effect of hypotonicity on AQP2 transcription. Our data suggest that two novel segments (؊283 to ؊252 and ؊157 to ؊126 bp) in the AQP2-promoter mediate the hypotonicity-induced AQP2 downregulation during vasopressin-escape.Renal water reabsorption is regulated by the hormone arginine vasopressin (AVP).2 AVP binding to its V2 receptor in renal principal cells induces a cAMP cascade leading to increased translocation of the water channel aquaporin-2 (AQP2) to the apical membrane, resulting in water reabsorption from the pro-urine (1). In addition to this short-term effect, cAMP increases AQP2 transcription through phosphorylation of the transcription factor CREB (cAMP responsive element-binding protein), which then binds to a cAMP responsive element (CRE) at Ϫ210 in the AQP2 promoter (2, 3). The increase in transcription is a more long-term effect, requiring hours to take effect. AVP synthesis and release are regulated by alterations in plasma osmolality as well as non-osmotic, baroreceptor-mediated pathways (4). Osmolality not only affects plasma AVP, but also appears to have direct effects on urine concentrating ability and AQP2 expression. In the syndrome of inappropriate antidiuretic hormone secretion (SIADH), for example, levels of AVP are inappropriately high relative to plasma osmolality, resulting in free-water retention and hypotonicity. Under these circumstances, however, the free-water excretion is considerably higher than would be expected from the vaso...